C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 0.86 AUD -3.37% Market Closed
Market Cap: AU$95.6m

Wall Street
Price Targets

CYC Price Targets Summary
Cyclopharm Ltd

Wall Street analysts forecast CYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYC is 1.53 AUD with a low forecast of 1.52 AUD and a high forecast of 1.58 AUD.

Lowest
Price Target
1.52 AUD
76% Upside
Average
Price Target
1.53 AUD
78% Upside
Highest
Price Target
1.58 AUD
83% Upside
Cyclopharm Ltd Competitors:
Price Targets
9688
Zai Lab Ltd
90% Upside

Revenue
Forecast

8% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
8% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 13 years the compound annual growth rate for Cyclopharm Ltd's revenue is 8%. The projected CAGR for the next 3 years is 38%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYC's stock price target?
Price Target
1.53 AUD

According to Wall Street analysts, the average 1-year price target for CYC is 1.53 AUD with a low forecast of 1.52 AUD and a high forecast of 1.58 AUD.

What is Cyclopharm Ltd's Revenue forecast?
Projected CAGR
38%

For the last 13 years the compound annual growth rate for Cyclopharm Ltd's revenue is 8%. The projected CAGR for the next 3 years is 38%.

Back to Top